Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations and Business Activities (Details)

v3.22.2.2
Nature of Operations and Business Activities (Details)
 3 Months Ended 9 Months Ended
Oct. 17, 2022
USD ($)
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Nov. 14, 2022
business_day
Nov. 10, 2022
USD ($)
Oct. 05, 2022
business_day
Dec. 31, 2021
USD ($)
Nature Of Operations And Business Activities [Line Items]                          
Working capital deficit   $ 3,462,290           $ 3,462,290          
Accumulated deficit   56,846,123           56,846,123         $ 47,256,163
Unrestricted cash   415,389     $ 11,089,624     415,389 $ 11,089,624       $ 8,983,007
Operating loss   (2,922,282)     (1,819,109)     (9,028,662) (5,386,044)        
Net loss   (3,127,283) $ (3,419,278) $ (3,043,399) $ (1,824,818) $ (2,024,027) $ (2,160,517) (9,589,960) $ (6,009,362)        
Multi-Draw Credit Agreement                          
Nature Of Operations And Business Activities [Line Items]                          
Outstanding principal balance   $ 2,464,500           $ 2,464,500          
Subsequent Event | Multi-Draw Credit Agreement                          
Nature Of Operations And Business Activities [Line Items]                          
Grace period (in days) | business_day                   30   30  
Subsequent Event | Discontinued Operations, Disposed of by Sale | Sale Of Subsidiary                          
Nature Of Operations And Business Activities [Line Items]                          
Aggregate purchase price                     $ 9,312,000    
Emerald Health Therapeutics, Inc.                          
Nature Of Operations And Business Activities [Line Items]                          
Exchange ratio   1.95           1.95          
Number of employees laid off   2                      
Working capital loan   $ 700,000                      
Emerald Health Therapeutics, Inc. | Subsequent Event                          
Nature Of Operations And Business Activities [Line Items]                          
Exchange ratio                     1.95    
Working capital loan $ 700,000